Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 8, 2008 Brian Orelli	Now That's the Way to Spin Off a Company The two spin-off companies formed from Abraxis Pharmaceutical, APP Pharmaceuticals and Abraxis BioScience, are worth almost double the value their parent had before the sale.
The Motley Fool February 29, 2008 Brian Orelli	Bigger Recall, No Big Deal Baxter increases its recall of heparin, but investors shouldn't be that worried.
The Motley Fool September 12, 2007 Brian Orelli	Fitting Fission at Abraxis BioScience Abraxis BioScience will split itself into a biotech firm and a generic drug business. Both new companies stand to benefit, but will investors?
The Motley Fool April 18, 2008 Brian Orelli	Recalls Can't Beat Baxter In spite of charges for two recalls, Baxter posts a decent quarter.
The Motley Fool November 12, 2007 Brian Orelli	Valuing a Breakup Abraxis makes its final earnings report before it becomes two companies. Its hospital-based products division will hereafter be known as APP Pharmaceuticals.
The Motley Fool July 6, 2007 Brian Orelli	Breaking Up Is Easy to Do Drugmaker Abraxis splits in two. It will be a few years before investors know whether the breakup was beneficial to the new companies.
The Motley Fool February 21, 2008 Brian Orelli	Watson Gets Less Generic Branded sales were up while generics fell for the year, which made Watson Pharmaceutical a more balanced company.
The Motley Fool April 2, 2008 Brian Orelli	Abraxis Tardy, but With a Note Abraxis Bioscience finally gets around to releasing fourth-quarter 2007 financials.
The Motley Fool November 10, 2005 Stephen D. Simpson	Hospitable Treatment for Hospira Solid margins fuel strong earnings at the hybrid generics - medical distributor. Buying this stock wisely may be the key to good long-term returns.
The Motley Fool April 10, 2008 Brian Orelli	The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company.
The Motley Fool April 7, 2008 Brian Orelli	Abraxis Tries On More Platform Shoes Abraxis BioScience announces that it is spending $15 million to pick up a small drugmaker, Shimoda Biotech.
The Motley Fool October 19, 2007 Brian Orelli	Baxter Gets Pumped Up Medical-device maker Baxter puts in a nice quarter despite two recent FDA recalls.
The Motley Fool February 21, 2008 Brian Lawler	A Bit of Irony From the FDA The agency has a mixed message on drug importation, as evidenced in the recent possible contamination of China-produced Heparin.
The Motley Fool April 22, 2005 Brian Gorman	Baxter Is on the Mend The medical products company continues to right itself for a brighter future. The firm's long-term positioning and diversified business may make it worth a closer look.
Bank Systems & Technology August 30, 2010 Matt Gunn	TD Bank Mobile App Hits iPhone, Android Toronto-based TD Bank announces the availability of its mobile app in both the iTunes App Store and Android Market.
The Motley Fool August 26, 2008 Brian Orelli	Baxter Ready to Sop Up Additional Revenue The health-care giant licenses a surgical sponge in clinical development.
The Motley Fool July 20, 2007 Brian Orelli	Baxter's Mixed Message A recall of Baxter BioScience's COLLEAGUE infusion pumps seems to have over-shadowed healthy quarterly earnings reports.
InternetNews July 30, 2010	Beta Version of RIM's App World 2 Opens With the new 2.0 version of App World, the app store for BlackBerry owners, RIM seems to have corrected some shortcomings. A beta version of the store is open for testing.
The Motley Fool January 25, 2008 Brian Orelli	Where the Big Margins Are Drug company investors get to enjoy such high gross margins, but there's generally only so much improvement that a company can make when it starts from such a high point. Take a look at some pharma companies that are succeeding to do just that.
Bank Systems & Technology July 6, 2010 Matt Gunn	Chase Adds Remote Deposit Capture, P2P Payments to iPhone App The Chase Mobile for iPhone and iPod touch app also lets users pay bills and credit cards, transfer money between accounts and now make payments to others through transactions triggered by email.
The Motley Fool February 28, 2007 Brian Lawler	Worrisome Watson The maker of generic drugs could have a challenging year ahead. Investors, take note.
IndustryWeek December 1, 2005 Traci Purdum	Microsoft Makes It a Double Redmond, Wash.-based Microsoft Corp. is investing $65 million to expand its presence in Humacao, Puerto Rico, to position itself as a "growth center" for Microsoft of the Americas through manufacturing and exporting CDs and DVDs.
InternetNews June 17, 2010 Andy Patrizio	RIM Overhauls BlackBerry App World The app store for the BlackBerry gets brought up to par with other online app stores in terms of features and options.
The Motley Fool August 10, 2006 Stephen D. Simpson	Volatility, Thy Name Is Hospira Margins continue to stand in the way of consistent performance at the health-care company. Investors, take note.
Fast Company Pavithra Mohan	Google's iOS App Just Got A Smart Update Now, you can ask Google anything while browsing pages in its app, and the app will respond based on what you are searching at the time.
InternetNews February 2, 2011	RIM's App World 2.1 Debuts With In-App Payments RIM's mobile app store now includes support for in-app payments, an improvement that will be particularly appreciated by gaming app developers.
InternetNews September 28, 2009	Apple's Bragging Rights: 2 Billion App Downloads Apple's App Store today surpassed 2 billion downloads, proving that the iPhone maker still reigns supreme in the mobile app world.
The Motley Fool August 13, 2007 Brian Orelli	Little Drug, Big Sales Huge increases in revenue usually drive stock prices upward, but Abraxis BioScience's stock has fallen 15% from its high last week, despite releasing a stellar earnings report.
InternetNews September 1, 2009	Enough With All the App Stores, Please Just because your phone offers downloadable apps doesn't mean it's a contender.
Fast Company David Lumb	Details Of Google Wireless Network Surface In Leaked Code Android Police just got a hold of leaked Google Android app files that, if they are legitimate, all but confirm several key features of Google's anticipated mobile service: a pay-by-the-gigabyte service that runs from an app.
Fast Company Dec 2013/Jan 2014 J.J. McCorvey	Productivity Apps Are Booming Here's why the productivity category is one of the hottest on the app market.
The Motley Fool April 20, 2006 Stephen D. Simpson	Baxter Bags Better Margins This is a great business -- but only at the right price. Investors, this story has to be bought cheap. At today's prices, is it cheap enough?
Bio-IT World June 15, 2003 Bob Violino	Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector
Information Today October 11, 2012	Presidential Documents App Available From GPO, National Archives The app is part of both agencies' efforts to support The White House's digital strategy for the federal government by ensuring the American people have access to government information on any device.
Fast Company Neal Ungerleider	Google Wallet Pivots -- And Turns Into Venmo Google Wallet, the company's NFC payment option that competes with Apple Pay and more conventional rivals like Paypal, is getting a facelift.
The Motley Fool November 9, 2006 Brian Lawler	Hospira's Flatlining Sales There's no good news to be found in this medical products supplier's medicine chest. The upcoming fourth quarter isn't going to be any better, either. Investors, take note.
AskMen.com	Best Health And Fitness Apps 2015 All you need is motivation, and a smartphone app (and most of them are free). So go get off your couch.
The Motley Fool November 3, 2011 Dan Caplinger	Has Baxter International Become the Perfect Stock? Baxter needs to keep working on getting its debt levels down and seek out new growth opportunities. With favorable demographic winds at its back, Baxter could be the rare stock to actually reach perfection.
The Motley Fool September 24, 2008 Brian Orelli	Hey, You! Stop! The FDA has ordered Baxter and Hospira to stop making their ophthalmic balanced salt solutions within 60 days.
BusinessWeek April 11, 2005 Arlene Weintraub	A Nano Drug's Giant Promise After seeking FDA approval for a decade, American Pharmaceutical Partners' Abraxane, which offers a less-toxic cancer treatment, has doctors and investors hopeful.
The Motley Fool June 25, 2009 Brian Orelli	Loss of a Settlement Option Earlier this month the Federal Trade Commission came out with a report arguing for limited patent protection for drugs made by biotech companies. Now it's ratcheting up its complaints about pharmaceutical and generic-drug companies as well.
IndustryWeek July 1, 2004 Karen M. Kroll	Life On The Island The life sciences industry taps Puerto Rico for tax breaks, educated workforce.
InsideFlyer December 2014	TripList App TripList, a free app for iOS, can eliminate some of the stress of holiday travel by helping you remember what to pack and allowing you to check off items and tasks as they are completed.
InternetNews December 2, 2010	Google Revs App Engine With Availability Focus With version 1.4 of its cloud-based App Engine, Google is promising to improve the delivery of applications through availability and real-time features.
InternetNews December 8, 2008 Richard Adhikari	Salesforce Intros Force.com for Google App Engine The relationship between the two cloud players gets even cozier.
Pharmaceutical Executive April 1, 2012 Jill Wechsler	Shortages and Sunshine Disclosure rules the day, as industry confronts demands to report supply problems, results of clinical trials, and payment to doctors.
The Motley Fool August 28, 2010 Daniel Bailey	App Store Crosses 250,000 Apps It's been little more than two years and Apple's app store is receiving some 600 new apps every day.
The Motley Fool October 8, 2007 Billy Fisher	A Menace to Big Pharma Abraxis gets tentative approval for a generic version of Pfizer's Camptosar. Many of the large-cap pharmaceutical companies are diversified to such a degree that they, like Abraxis, present interesting plays on the threat posed by generics.
InternetNews May 19, 2010	Google Launches App Engine for Business Google is upping the ante on its enterprise push, rolling out a new version of its App Engine geared specifically for enterprises and forging a new partnership with VMware.
The Motley Fool November 11, 2004 Brian Gorman	Hospira's Possibilities The medical products and services outfit is not flashy, but it may benefit from long-term trends. Their stock may be worth monitoring.